Q9992 Medicaid Rate by State

Injection, buprenorphine extended-release (sublocade), greater than 100 mg

30 state Medicaid programs publish a fee-for-service rate for Q9992 (injection, buprenorphine extended-release (sublocade), greater than 100 mg), ranging from $1,674.80 in Arkansas to $2,312.13 in Indiana among rates on the same basis.

Every state, kept current

Every code in every state: the Rates plan

$29 /mo, 7-day free trial

  • Every code on all 51 published schedules
  • Full-schedule CSV export and state network lists
  • Email alerts when a state changes its rates
Start free trial$29/mo after the trial; a trial exports 50-row samples

Or one file, no account: State-Specific Services across 45 states, 1,475 codes.

2026-11-19 edition, standardized by ProviderSignal. Secure checkout by Stripe; download link by email, 5 downloads in 30 days. License · Every file we sell

Publishing states

30

Median % of Medicare

--

Rate range, like rates

$1,674.80 - $2,312.13

Q9992 rates in every publishing state

  • Alabama$2,016.42

    2026

  • Arkansas$1,674.80

    2026

  • Arizona$1,835.22

    surgery center payment

    2026

  • California$2,001.02

    2026

  • Connecticut$1,998.53

    2026

  • District of Columbia$1,998.53

    Prior auth: not required, 2026

  • Iowa$1,945.08

    2025

  • Illinois$1,942.65

    2026

  • Indiana$2,312.13

    Prior auth: required, 2026

  • Kansas$2,068.16

    2026

  • Kentucky$1,998.53

    surgery center payment

    2026

  • Maryland$1,998.53

    2026

  • Maine$2,068.16

    2026

  • Michigan$2,068.16

    2026

  • Minnesota$2,068.15

    Prior auth: required, 2026

  • Mississippi$1,996.56

    2026

  • Montana$1,998.53

    variant HG

    Prior auth: required, 2026

  • Nebraska$2,068.15

    2026

  • New Hampshire$2,202.03

    Prior auth: not required, 2026

  • New Jersey$1,901.30

    Prior auth: not required, 2026

  • New Mexico$1,931.81

    2025

  • Oklahoma$2,060.13

    2026

  • South Carolina$2,060.13

    2026

  • Texas$1,976.55

    2026

  • Utah$2,068.16

    Prior auth: required, 2026

  • Virginia$2,068.15

    2026

  • Vermont$1,915.60

    2026

  • Washington$2,068.16

    2026

  • Wisconsin$2,068.16

    2026

  • Wyoming$2,068.16

    2026

Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. A state that lists the code more than one way shows one of its rows here, with its basis: a rental is not a purchase price. "--" in the prior-auth column means the state publishes no PA flag.

Related state-specific services codes

All 22 codes from Q9950 to Q9999 or every state-specific services code by number.

Frequently asked questions

How much does Medicaid pay for Q9992?

30 state Medicaid programs publish a fee-for-service rate for Q9992 (injection, buprenorphine extended-release (sublocade), greater than 100 mg), ranging from $1,674.80 in Arkansas to $2,312.13 in Indiana among rates on the same basis. The full table on this page lists every publishing state's current rate.

Which state pays the most for Q9992?

Indiana publishes the highest Medicaid rate for Q9992 at $2,312.13. Arkansas publishes the lowest at $1,674.80, among rates on the same basis; rentals and rates far from the other states' are in the table with their basis.

Does Q9992 require prior authorization under Medicaid?

4 of the 30 publishing states flag Q9992 as requiring prior authorization (always or conditionally) on their fee schedules. States without a flag publish no PA indicator for this code - that means "not published", not "no PA required".